{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:37Z","timestamp":1793413477438,"version":"4.5.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Pertussis remains a significant global public health challenge, particularly in China, where no licensed pertussis-containing vaccines are available for individuals aged 6 years and older. This blind, randomised, and controlled phase I clinical trial evaluated the safety and immunogenicity of the Tetanus, Reduced Diphtheria, and Acellular Pertussis (Five Components) Combined Vaccine, Adsorbed (Tdcp). Participants aged 6 years and above were divided into three age subgroups (6\u201311, 12\u201317, and \u226518 years) and randomised to receive Tdcp or control vaccines (PPV23 or DT). Safety endpoints included the incidence of adverse reactions within 30 days post-vaccination, while immunogenicity was assessed through seroconversion rates and geometric mean concentrations (GMCs) of anti-DT, TT, PT, FHA, PRN, and FIM 2&amp;amp;3 antibodies at 30 days post-vaccination. Among 178 participants, the incidence of total adverse reactions in the Tdcp group was 54.62%, primarily local reactions such as pain and itching, with no significant differences compared to controls (p &amp;gt; 0.05). Immunogenicity analysis revealed robust immune responses in the Tdcp groups, with seroconversion rates for pertussis-related antigens exceeding 75% in all age groups. The GMCs for anti-PT antibodies reached 125.60 IU\/mL, 150.28 IU\/mL, and 131.14 IU\/mL in the \u226518 years, 12\u201317 years, and 6\u201311 years of Tdcp groups, respectively. Overall, the Tdcp vaccine demonstrated a good safety profile and robust immunogenicity in participants aged 6 years and above. The inclusion of five pertussis antigens, particularly PT, elicited strong immune responses, supporting its potential as an effective booster vaccine for adolescents and adults.<\/jats:p><jats:sec><jats:title>Clinical trial registration<\/jats:title><jats:p><jats:uri>https:\/\/clinicaltrials.gov\/<\/jats:uri>, identifier NCT06056050.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1616574","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:22:05Z","timestamp":1757049725000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Preliminarily evaluation the safety and immunogenicity of tetanus, reduced diphtheria and acellular pertussis (five components) combined vaccine, adsorbed (Tdcp) in participants aged 6 years and above: a blinded and randomised, and controlled phase I clinical trial"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuewen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwen","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20152309","DOI":"10.1098\/rspb.2015.2309","article-title":"The pertussis enigma: reconciling epidemiology, immunology and evolution","volume":"283","author":"Domenech de Cell\u00e8s","year":"2016","journal-title":"Proc Biol Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1001\/jama.2024.9049","article-title":"What is pertussis","volume":"332","author":"Scruggs-Wodkowski","year":"2024","journal-title":"JAMA"},{"key":"B3","unstructured":"Whooping cough (pertussis)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"106289","DOI":"10.1016\/j.jinf.2024.106289","article-title":"Global resurgence of pertussis: A perspective from China","volume":"89","author":"Liu","year":"2024","journal-title":"J Infect"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2025.101628","article-title":"Waning immunity, prevailing non-vaccine type ptxP3 and macrolide-resistant strains in the 2024 pertussis outbreak in China: a multicentre cross-sectional descriptive study","volume":"60","author":"Cai","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"B6","article-title":"Type of clustering of pertussis cases in Tianjin","volume":"29","author":"Huang","year":"2014","journal-title":"Dis Surveill"},{"key":"B7","unstructured":"Pertussis-annual epidemiological report for 2022\n          \n          \n          \n          2024"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.02.032","article-title":"Seroepidemiology of pertussis in China: A population-based, cross-sectional study","volume":"39","author":"Zhang","year":"2021","journal-title":"Vaccine"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2025.2459745","article-title":"Dilemma in prevention of pertussis infection among infants under six months in China","volume":"24","author":"Sun","year":"2025","journal-title":"Expert Rev Vaccines"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa469","article-title":"Pertussis (Whooping cough)","volume":"224","author":"Decker","year":"2021","journal-title":"J Infect Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1278513","article-title":"Surveillance for adverse events following immunization with DTaP-containing combination vaccines in Linping, China, 2019-2022","volume":"12","author":"Chen","year":"2024","journal-title":"Front Public Health"},{"key":"B12","unstructured":"BOOSTRIX"},{"key":"B13","unstructured":"Adacel"},{"key":"B14","unstructured":"FAQs on the Adjustments to the Immunization Schedule for the DTP Vaccine and the DT Vaccine under the National Immunization Program"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1054617","article-title":"Seroepidemiology of pertussis in the east of China: Estimates of incidence of infection in adolescents and adults pre- and post-COVID-19","volume":"10","author":"Chen","year":"2022","journal-title":"Front Public Health"},{"key":"B16","doi-asserted-by":"publisher","first-page":"106322","DOI":"10.1016\/j.jinf.2024.106322","article-title":"Household transmission patterns and serial interval of pertussis in China","volume":"89","author":"Su","year":"2024","journal-title":"J Infect"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.11.028","article-title":"Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19\u201364 years of age","volume":"27","author":"Blatter","year":"2009","journal-title":"Vaccine"},{"key":"B18","doi-asserted-by":"publisher","first-page":"10503","DOI":"10.4161\/hv.6.3.10503","article-title":"Booster vaccination against pertussis in Chinese children at six years of age using reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (Boostrix\u2122)","volume":"6","author":"Zhu","year":"2010","journal-title":"Hum Vaccin"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1062954","article-title":"Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study","volume":"11","author":"Li","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2017.1417632","article-title":"Challenges in adult vaccination","volume":"50","author":"de Gomensoro","year":"2018","journal-title":"Ann Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1616574\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T05:22:09Z","timestamp":1757049729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1616574\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":20,"alternative-id":["10.3389\/fimmu.2025.1616574"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1616574","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1616574"}}